“Careful scrutiny” of rising drug use, spending in BC recommended Clinical study 30 January 2013 Pages: 2 - 2
Barriers to psychiatric care in general practice not surprising Correspondence 30 January 2013 Pages: 2 - 2
In-hospital costs of CABG markedly greater in the US than in Canada Clinical study 30 January 2013 Pages: 4 - 4
Continue with heparin until antibody test suggests otherwise Clinical study 30 January 2013 Pages: 5 - 5
Intervention successful in reducing antibacterial prescribing for UTIs Clinical study 30 January 2013 Pages: 5 - 5
Lowering the age of influenza vaccination worth it in Europe? Clinical study 30 January 2013 Pages: 5 - 5
Opportunistic screening for oral cancer cost effective in the UK Clinical study 30 January 2013 Pages: 6 - 6
Treatment of GERD influenced by physician characteristics Clinical study 30 January 2013 Pages: 7 - 7
Substantial cost burden of inpatient staphylococcal infection Clinical study 30 January 2013 Pages: 8 - 8
Long-acting risperidone a cost-effective choice in Taiwan Clinical study 30 January 2013 Pages: 9 - 9
Parents not aware of OTC antidiarrhoeal options for children Media release 30 January 2013 Pages: 9 - 9
Wait-and-see strategy applicable in paediatric otitis media Clinical study 30 January 2013 Pages: 9 - 9
Cotrimoxazole prophylaxis cost effective for HIV in the Ivory Coast Clinical study 30 January 2013 Pages: 11 - 11
Highest-risk patients miss out on much-needed HF therapy Clinical study 30 January 2013 Pages: 11 - 11
Salmeterol/fluticasone propionate more cost effective in asthma Clinical study 30 January 2013 Pages: 11 - 11
Which screening strategy for congenital hypothyroidism best? Clinical study 30 January 2013 Pages: 12 - 12
Acetylcholinesterase inhibitors: modest improvements in AD Clinical study 30 January 2013 Pages: 13 - 13
Etanercept a relief for patients with ankylosing spondylitis Clinical study 30 January 2013 Pages: 13 - 13
The delivery of a pharmaceutical care programme can lead to improvements in symptoms and QOL for patients with heart failure (HF) Clinical study 30 January 2013 Pages: 13 - 13
Response to chemo improves QOL in advanced ovarian cancer Clinical study 30 January 2013 Pages: 13 - 13
Novartis' type 2 DM drugs set to achieve blockbuster status Media release 30 January 2013 Pages: 14 - 14
The long-acting injection formulation of risperidone [Risperdal Consta] will be fully funded for patients with psychotic disorders in New Zealand (NZ) from 1 October this year Media release 30 January 2013 Pages: 14 - 14
WHO announces global focus on maternal/child health, polio eradication News item 30 January 2013 Pages: 14 - 14
Merck announces emergency 30-day drug supply in wake of Hurricane Katrina Media release 30 January 2013 Pages: 15 - 15